Kamran Alam
CHIEF FINANCIAL OFFICER · 2 filings · Latest: Feb 4, 2026
Taysha Gene Therapies, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TSHA | Kamran Alam | CHIEF FINANCIAL OFFICER | Feb 4, 2026 | Sale | $4.52 | 1,655 | $7.5K | 1,442,131 | |
TSHA | Kamran Alam | — | Feb 4, 2026 | Proposed Sale | $4.72 | 1,655 | $7.8K | — | |
TSHA | Kamran Alam | CHIEF FINANCIAL OFFICER | Jan 26, 2026 | Sale | $4.61 | 23,849 | $109.9K | 1,443,786 | |
TSHA | Kamran Alam | CHIEF FINANCIAL OFFICER | Jan 23, 2026 | Sale | $4.75 | 78,968 | $375.1K | 1,467,635 | |
TSHA | Kamran Alam | — | Jan 23, 2026 | Proposed Sale | $5.09 | 100,846 | $513.3K | — | |
TSHA | Kamran Alam | — | Aug 21, 2025 | Proposed Sale | $2.87 | 54,491 | $156.4K | — |